How much did QurAlis raise?

QurAlis raised $33.2 Million in a funding round on May 18, 2020.

Where is QurAlis based and how big is it?

QurAlis is based in Cambridge, Massachusetts, United States. Fundz records about 94 employees.

Who are the decision-makers at QurAlis?

Fundz holds 1 contact at QurAlis, including the Executive Officer. Names and contact details are shown to Fundz members.

Qur Alis Corp reported raising $33.2 Million in an initial SEC Form D filing, from an offering of $60 Million

PRIVATEMay 18, 2020$33.2M of $60M raised

Amount Raised

$33.2 Million

$33.2 Million sold, per SEC Form D (first sale May 18, 2020)

Round Type

Venture

CambridgeBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

QurAlis raised $33.2 Million in a funding round, dated May 18, 2020. QurAlis is based in Cambridge, Massachusetts, United States.

How much did QurAlis raise?: QurAlis raised $33.2 Million in a funding round on May 18, 2020.
What does QurAlis do?: QurAlis is a pioneering neuroscience company dedicated to developing precision medicines that target the root causes of neurodegenerative and neurological diseases.
Where is QurAlis based and how big is it?: QurAlis is based in Cambridge, Massachusetts, United States. Fundz records about 94 employees.
Who are the decision-makers at QurAlis?: Fundz holds 1 contact at QurAlis, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as QurAlis that raised within 45 days of this round, from Fundz verified event records.

Amylyx Pharmaceuticals raised $30M on July 1, 2020.
Azora Therapeutics, Inc. (DE) raised $5.2M on June 17, 2020.
Mereo Biopharma Group plc raised $70M on June 12, 2020.
BioLineRx Ltd raised $4.4M (Pre-Seed) on June 10, 2020.
BioLineRx Ltd raised $9M on June 10, 2020.
Definium Therapeutics raised $468K (Seed) on June 8, 2020.

Who to call at QurAlis, and when

A new round usually means QurAlis is about to hire and buy. The teams that reach out first get the meeting.

An alert the day QurAlis raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at QurAlis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at QurAlis. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

QurAlis

Location

Cambridge, Massachusetts, United States

About

QurAlis is a pioneering neuroscience company dedicated to developing precision medicines that target the root causes of neurodegenerative and neurological diseases. With leading expertise in amyotrophic lateral sclerosis (ALS), the company is committed to translating scientific breakthroughs into transformative therapies. Guided by collaboration, scientific rigor, and compassion, QurAlis is advancing a robust pipeline of disease-modifying treatments driven by genetics and clinical biomarkers to improve the lives of patients with severe neurological conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment QurAlis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contactsDaniel E., Executive Officer hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for QurAlis's next move

See what Strategic adds

QurAlis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.